AS (Guilin Pharmaceuticals)

DRUG2 trials

Sponsors

London School of Hygiene and Tropical Medicine

Conditions

Malaria

Phase 3

Parasite Clearance and Protection From Infection (PCPI) in Zambia

CompletedNCT06166498

London School of Hygiene and Tropical MedicineMalaria

Start: 2024-07-24End: 2025-03-05Updated: 2025-03-12

Parasite Clearance and Protection from Infection (PCPI) in Cameroon

CompletedNCT06173206

London School of Hygiene and Tropical MedicineMalaria

Start: 2024-06-10End: 2025-03-05Updated: 2025-03-12

Related Papers

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Zambia.

2025-11-11

Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3-5 years of age in Cameroon.

2024-09-261 citations